✦ LIBER ✦

Does imatinib mesylate (IM) affect longterm outcome in patients with gastrointestinal stromal tumors (GISTs)?

✍ Scribed by Judy Jin; Ann Robinson; Joseph Willis; Jeffrey Hardacre; Julian Kim

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic changes in advanced gastrointest

✍ Chun-Nan Yeh; Tsung-Wen Chen; Feng-Yuan Liu; Yi-Yin Jan; Miin-Fu Chen 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 289 KB

Surgical management in metastatic gastro

✍ Chun-Nan Yeh; Tsung-Wen Chen; Jeng-Hwei Tseng; Yu-Yin Liu; Shang-Yu Wang; Chun-Y 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

A metastatic case of gastrointestinal st

✍ D.A. Diallo; M. Ly; G. Diallo; A.K. Dembélé; M. Touré; B.A. Touré; A. Koné; S. S 📂 Article 📅 2011 🏛 Elsevier 🌐 French ⚖ 262 KB

Surgical intervention following imatinib

✍ Sun Jin Sym; Min-Hee Ryu; Jae-Lyun Lee; Heung Moon Chang; Tae-Won Kim; Hee Cheol 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Surgical treatment of patients with init

✍ Piotr Rutkowski; Zbigniew Nowecki; Pawel Nyckowski; Wirginiusz Dziewirski; Urszu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

Imatinib mesylate-induced acute liver fa

✍ Onder Tonyali; Ugur Coskun; Ramazan Yildiz; Tarkan Karakan; Umut Demirci; Nalan 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 256 KB